Skip to main content
. 2022 Aug 6;13(8):687. doi: 10.1038/s41419-022-05117-9

Fig. 1. ErbB2 downregulates BLNK in detached breast cancer cells.

Fig. 1

A MCF10A and MCF-ErbB2 cells were cultured detached from the ECM (3D) for 24 h and BLNK mRNA levels were analyzed in the cells by quantitative PCR (qPCR). BLNK mRNA levels normalized by those of 18 S rRNA (determined by qPCR) expressed in arbitrary units are shown. Results represent the average of three independent experiments plus the SD. *p-value is < 0.05. B MCF10A and MCF-ErbB2 cells were cultured attached to (2D) or detached from (3D) the ECM for the indicated times and assayed for BLNK levels by western blotting. α-tubulin was used as a loading control. CE Human ErbB2-positive cell lines AU565, SKBR3 and BT474 were cultured attached to (2D) (left) or detached from the ECM (3D) (right) for 48 h in the absence (−) or in the presence (+) of 5 μg/ml trastuzumab (TZ) and assayed as in (B). F Trastuzumab-resistant variant of BT474 cells BT474TR was assayed as in (CE).